Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cordlife Group ( (SG:P8A) ) has provided an update.
Cordlife Group Limited has completed a technical analysis on its Additional Low-Risk Tanks Test Results and is conducting a comprehensive review, which will not be included in the FY2024 Audited Financial Statements. The company is working with auditors to finalize these statements and plans to announce them and hold the AGM by June 2025. Additionally, Cordlife will delay the release of its 1Q2025 Financial Statements but will continue to provide quarterly business updates, with the next update expected by mid-June 2025.
More about Cordlife Group
Cordlife Group Limited is a company registered in Singapore, operating in the healthcare industry. It focuses on providing cord blood banking services and other related healthcare services.
Average Trading Volume: 102,126
Technical Sentiment Signal: Strong Sell
Current Market Cap: S$39.57M
For an in-depth examination of P8A stock, go to TipRanks’ Stock Analysis page.